Our company

Cygnus Pharmaceutical group was incorporated in Bulgaria in 2017, initially working with APIs and selected pharmaceutical raw materials. In 2019, we introduced our own line of finished products. Today, the range includes injectable and oral formulations, while work with selected APIs remains part of the business.

What we do today

We manage product development, supplier selection and quality review across the range. This work is carried out in cooperation with established distribution partners, with attention to how products are supplied, identified and used in practice.

How we support our products

Selected product samples are submitted for independent analytical testing, with the results published through Cygnus channels. A unit-level verification system also allows every supplied item to be checked for authenticity.

How the portfolio develops

New products are considered through a combination of market demand, partner feedback and internal development priorities. The aim is not to build the largest possible catalogue, but to add products that have a clear place within the range.

6

Distribution partners

45

Products in portfolio

Focused on quality and product consistency

Cygnus Pharmaceutical group applies a structured approach to product development, supplier selection and quality control. The company focuses on consistency, analytical review and practical product requirements across its finished product and API-related activities.

Portfolio development and supply cooperation

We continue to develop our portfolio in response to market demand and professional partner feedback. Our activities cover injectable and oral finished products, selected APIs and pharmaceutical raw materials for professional distribution channels.